Vasopressin NDC 51662-1688

Product information

Brand name (proprietary)

Vasopressin

Generic name (nonproprietary)

vasopressin

Active ingredients

Vasopressin — 20 [USP'U]/mL

Dosage form

Injection, Solution

Route

Intravenous

Labeler

HF Acquisition Co LLC, DBA HealthFirst

Product type

Prescription drug

Marketing category

NDA — New Drug ApplicationApplication NDA 212593

Marketing start

Feb 3, 2022

Listing expires

Dec 31, 2027

Other FDA classes

Decreased Diuresis (Physiologic effect)Vasoconstriction (Physiologic effect)Vasopressins (Chemical structure)

Identifiers

Product ID 51662-1688_564adf55-3c43-498c-e063-6294a90a5600SPL ID 564adf55-3c43-498c-e063-6294a90a5600SPL set ID 52324969-4536-2b7c-e063-6394a90a9b4dRxCUI 2103182UNII Y4907O6MFD

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N451662168802 followed by a unit qualifier and the quantity Copy

Package 51662-1688-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under NDA 212593

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.